About Darryl

This author has not yet filled in any details.
So far Darryl has created 49 blog entries.

Over 20,000 Have Pledged to Boycott CVS & Caremark until they sell Cancer Drugs Again- CVS removing many cancer drugs, including Xtandi, from it’s formulary

Sign pledge to boycott CVS here: CVS Pharmacy will hurt many cancer patients by removing dozens of cancer treatment drugs, like leukemia drug Tasigna, prostate cancer drug Xtandi and chemotherapy treatment drug Neupogen, from their formulary, starting in 2017. CVS claims these drugs cost too much. Go ahead and tell that to my insurance provider and Medicare but don’t stop selling these drugs to me and millions of cancer patients. It's our belief that CVS is putting profit above the care of cancer patients. If CVS can make money by selling cheap cosmetics and imported cookies, then, we imagine [...]

By | November 3rd, 2016|advocacy|0 Comments

Prostate Cancer Podcast – Is Prostate Cancer Inherited?

Family history and genetics. Prostate cancer is often referred to as a family disease. Is it and what does this actually mean?   Malecare's Advanced Prostate Cancer Program Director, Joel Nowak, interviews Dr. Lorelei A. Mucci. Dr. Mucci is an epidemiologist specializing in prostate cancer. She works at the Harvard University School of Public Health in Boston, Massachusetts. click on read more, below, to listen:

By | May 13th, 2016|Uncategorized|0 Comments

UPDATE: Malecare Advocacy Restores CDC Prostate Cancer Funding

UPDATE June 9, 2016 The Senate Appropriations Committee voted to approve its FY17 Labor-HHS Appropriations bill earlier today, with only one senator, Bill Cassidy (R-LA), voting against the bill. Funding for the Centers for Disease Control's Prostate Cancer activities program was restored!!! Thanks to all of Malecare's Patient Advocacy Leaders and ALL of You who sent emails and made phone calls to the Senate Appropriations Committee The USA federal Fiscal Year (FY) 2017 Budget eliminates funding ($13.2 million) for the entire Prostate Cancer program at the Centers for Disease Control (CDC). Malecare asks for your advocacy for restoring that funding. [...]

By | March 28th, 2016|advocacy|0 Comments

ZYTIGA – Potential Dosing Error – IMPORTANT

Error in ZYTIGA® Beginning Your Treatment Brochure It has come to Malecare's attention that the dosing schedule for ZYTIGA® (abiraterone acetate) is incorrectly described in the ZYTIGA® Beginning Your Treatment brochure. Please destroy the ZYTIGA® Beginning Your Treatment brochure and the ZYTIGA® Resource Kit. It contains inaccurate dosing information. Please ask your doctor, today, to ensure that you understand the appropriate dosing for ZYTIGA®. The recommended dose for ZYTIGA® is 1,000 mg (four 250-mg tablets) administered orally once daily [in combination with prednisone 5 mg administered orally twice daily]. It is a massive shame on JANSSEN that Malecare has found this out, indirectly. Patients, through their advocacy organizations like Malecare, should have [...]

By | February 12th, 2016|Uncategorized|4 Comments